FindTrial
Sign In

Steroid withdrawal after simultaneous pancreas and kidney transplantation in patients with end-stage diabetic nephropathy

Steroid withdrawal after simultaneous pancreas and kidney transplantation in patients with end-stage diabetic nephropathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037977
Enrollment
Unknown
Registered
2020-09-08
Start date
2021-10-01
Completion date
Unknown
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Terminal Stage of Diabetes Complicated with Nephrosis

Interventions

Group 1:remove steroid early
Group 2:remove steroid usually

Sponsors

The Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of patients with end-stage diabetic nephropathy 2. Aged 18-70 years 3. Simultaneous pancreas and kidney transplantation was performed for all patients, which was the first transplantation 4. Preoperative PRA was negative, and donor lymphotoxicity test was negative

Exclusion criteria

Exclusion criteria: 1. Diagnosis of end-stage renal disease complicated with diabetes; 2, Pregnancy or plan for pregnancy; 3. Patients with malignant tumors.

Design outcomes

Primary

MeasureTime frame
amylase;—

Countries

China

Contacts

Public ContactZheng Chen

The Second Affiliated Hospital of Guangzhou Medical University

docchenzheng@163.com+86 13808896300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026